Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
ProMIS Neurosciences Inc. (PMN)
|
|
| Income Statement |
|
|
|
| Standardized | As Reported |
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 |
| Revenue growth | | 49.8% | -7.4% | | | | | |
| Cost of goods sold | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.2 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | | 0.0% | 0.0% | | | 0.0% | 0.0% | |
| Selling, general and administrative [+] | 1.9 | 1.5 | 2.1 | 1.5 | 1.6 | 2.0 | 1.7 | 1.3 |
| General and administrative | 1.9 | 1.5 | 2.1 | 1.5 | 1.6 | 2.0 | 1.7 | 1.3 |
| Research and development | 1.0 | 3.5 | 6.4 | 4.6 | 3.2 | 1.9 | 2.8 | 0.8 |
| EBITDA [+] | | -5.0 | -8.5 | -6.1 | -4.9 | -3.9 | -4.5 | -2.1 |
| EBITDA growth | -40.4% | 26.3% | 87.8% | 193.9% | 344.6% | | | |
| EBITDA margin | | -3361.4% | -5742.1% | | | -3987.7% | -2831.8% | |
| Depreciation | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBITA | -2.9 | -5.0 | -8.5 | -6.1 | -4.9 | -3.9 | -4.5 | -2.1 |
| EBITA margin | | -3361.6% | -5742.3% | | | -3989.5% | -2837.0% | |
| Amortization of intangibles | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EBIT [+] | -2.9 | -5.0 | -8.5 | -6.1 | -4.9 | -3.9 | -4.5 | -2.1 |
| EBIT growth | -40.4% | 26.2% | 87.4% | 192.3% | 340.1% | | | |
| EBIT margin | | -3362.5% | -5743.1% | | | -3990.8% | -2837.8% | |
| Interest expense | 0.0 | | | | 0.1 | 0.1 | 0.1 | 0.1 |
| Interest expense | 0.0 | | | | 0.1 | 0.1 | 0.1 | 0.1 |
| Other income (expense), net | 0.6 | 0.0 | 1.3 | 0.1 | 2.3 | 2.0 | 2.4 | 1.0 |
| Pre-tax income | -2.3 | -5.0 | -7.3 | -6.0 | -2.7 | -2.1 | -2.2 | -1.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -2.3 | -5.0 | -7.3 | -6.0 | -2.7 | -2.1 | -2.2 | -1.2 |
| Net margin | | -3382.3% | -4893.8% | | | -2122.7% | -1400.9% | |
| |
| Basic EPS [+] | ($0.27) | ($0.58) | ($0.97) | ($0.83) | ($0.38) | ($0.29) | ($0.39) | ($0.20) |
| Growth | -29.7% | 100.2% | 149.5% | 307.7% | 762.5% | | | |
| Diluted EPS [+] | ($0.27) | ($0.58) | ($0.97) | ($0.83) | ($0.38) | ($0.29) | ($0.39) | ($0.20) |
| Growth | -29.7% | 100.2% | 149.5% | 307.7% | 762.5% | | | |
| |
| Shares outstanding (basic) [+] | 8.6 | 8.6 | 7.5 | 7.2 | 7.2 | 7.2 | 5.8 | 5.9 |
| Growth | 19.2% | 19.2% | 29.7% | 21.6% | 41.1% | | | |
| Shares outstanding (diluted) [+] | 8.6 | 8.6 | 7.5 | 7.2 | 7.2 | 7.2 | 5.8 | 5.9 |
| Growth | 19.2% | 19.2% | 29.7% | 21.6% | 41.1% | | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|